Background: There are some reports of paradoxical inflammation phenomena associated with anti-TNF therapy in patients with inflammatory bowel disease (IBD). The aim of this study has been to evaluate the incidence of paradoxical inflammation phenomena in patients with inflammatory bowel disease (IBD) treated with infliximab (IFX).Methods: The authors carried out a retrospective analysis of 64 patients with IBD ...